Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Esther Plensa"'
Autor:
Silvia Marce Torra, Aleix Méndez, Antonella Luciana Sturla, Miriam Ratia, Anna Angona Figueras, Paula Amat, Francisca Ferrer-Marín, Silvia Escribano, Emilia Scalzulli, Montserrat Cortes Sansa, Esther Plensa, Natalia Estrada, Marta Cabezon Marco, Mireia Morgades, Maria Alicia Senin Magan, Juan Carlos Hernandez-Boluda, Eduardo Anguita, Massimo Breccia, Valentín García-Gutiérrez, Blanca Xicoy Cirici, Lurdes Zamora
Publikováno v:
HemaSphere, Vol 7, p e153219d (2023)
Externí odkaz:
https://doaj.org/article/8dad2001e1af4ba89b7deb1f863173f2
Publikováno v:
Medicina Clínica. 160:172-178
Autor:
Mercè Aren, Silvia Marce, Rebeca Jurado, Gustavo Tapia, Lluís Puigdefabregues, Minerva Raya, Montserrat Cortes, Montse Garcia‐Caro, Jordi Junca, Pablo Mozas, Esther Viñets, Marta Cabezon, Esther Plensa, Milos Miljkovic, Juan‐Manuel Sancho, José‐Tomas Navarro, Lurdes Zamora, Marc Sorigue
Publikováno v:
Cytometry. Part B, Clinical cytometryREFERENCES. 102(6)
High-quality data on bone marrow involvement (BMI) assessed by flow cytometry (FC) in follicular lymphoma (FL) is lacking.We set up a prospective protocol with a 10-color tube and acquisition of 500.000 leukocytes on a Nav flow cytometer for evaluati
Publikováno v:
Medicina clinica.
Autor:
Sílvia Beà, Diana Marcela Ruíz Domínguez, Sara Vergara, Esther Plensa, Silvia-Zdenka Mostacedo, Andrea Espasa, Marc Sorigue, Christelle Ferra, Laia Pinyol, Rocio Ruiz, Joan Buch, Jessica Aranda, Lurdes Zamora, Gustavo Tapia, Marta Cabezón, Silvia Marcé, Neus Ruiz-Xivillé, Isabel Granada, Laia Lopez-Viaplana, José-Tomás Navarro, Jordi Juncà, Minerva Raya
Publikováno v:
Cytometry Part B: Clinical Cytometry. 98:421-428
BACKGROUND Within the hematopoietic compartment, fibromodulin (FMOD) is almost exclusively expressed in chronic lymphocytic leukemia (CLL) lymphocytes. We set out to determine whether FMOD could be of help in diagnosing borderline lymphoproliferative
Autor:
Gonzalo Hernández, Xenia Ferrer-Cortès, Veronica Venturi, Melina Musri, Martin Floor Pilquil, Pau Marc Muñoz Torres, Ines Hernandez Rodríguez, Maria Àngels Ruiz Mínguez, Nicholas J. Kelleher, Sara Pelucchi, Alberto Piperno, Esther Plensa Alberca, Georgina Gener Ricós, Eloi Cañamero Giró, Santiago Pérez-Montero, Cristian Tornador, Jordi Villà-Freixa, Mayka Sánchez
Publikováno v:
Genes, Vol 12, Iss 1980, p 1980 (2021)
Genes; Volume 12; Issue 12; Pages: 1980
Genes
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Genes; Volume 12; Issue 12; Pages: 1980
Genes
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Hereditary hemochromatosis (HH) is an iron metabolism disease clinically characterized by excessive iron deposition in parenchymal organs such as liver, heart, pancreas, and joints. It is caused by mutations in at least five different genes. HFE hemo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lurdes Zamora, Blanca Xicoy, Marta Cabezón, Alberto Pineda, Silvia Marcé, Francisco Fuster-Tormo, Isabel Granada, Esther Plensa, Laura Palomo, Marisol Xandri, Francesc Solé, Evarist Feliu, Concepción Boqué, Pamela Acha, Dolors Vela, Miguel Sagüés
Publikováno v:
American journal of hematology. 94(10)
Autor:
C. Fernández, Silvia Marcé, Olga García, Marta Cabezón, Concepción Boqué, Blanca Xicoy, Josep-Maria Ribera, Montserrat Cortés, Esther Plensa, Marc Sorigue, Patricia Velez, Evarist Feliu, Joan Buch, Lurdes Zamora, David Gallardo
Publikováno v:
European Journal of Haematology. 97:331-335
OBJECTIVE Somatic mutations in ASXL1 seem to have a negative prognostic impact in patients with several myeloid neoplasms, including myelofibrosis (MF). The aim of this work was to determine the prevalence and profile of ASXL1 mutations in MF. METHOD
Autor:
Pável Olivera, Miren Gabilondo, Mireia Constans, Dolors Tàssies, Esther Plensa, Verónica Pons, Germán Las Heras, Carmen Jiménez, Desirée Campoy, Anna Bustins, Artur Oliver, Cristina Marzo, Tania Canals, Anna Varela, Marc Sorigue, Eva Sánchez, Gabriela Ene, Granada Perea, Laura Vicente, Meritxell López, María Cerdá, Erik Johansson, M. Reyes Aguinaco, Nazly Santos, José Mateo, Joan Carles Reverter, Ángel Moya, Amparo Santamaría
Publikováno v:
Medicina clinica. 151(5)
In recent years, direct oral anticoagulants (DOACs) have become an alternative to vitamin K antagonists (VKA) for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF) as well as for prevention and tr